Ibrutinib, Lenalidomide, and Dexamethasone in Treating Patients With Multiple Myeloma Ineligible for Transplant
Clinical trial NCT03015792 · TERMINATED
Trial details
- NCT number
- NCT03015792
- Sponsor
- Mayo Clinic
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-10
- Primary completion
- 2022-10-18
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.